The largest database of trusted experimental protocols

4 protocols using anti mouse il 10

1

Quantitative Mouse IL-10 ELISA Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wells were coated overnight at 4°C with anti-mouse IL-10 (R and D Systems) in coating buffer (0.0125M sodium bicarbonate plus 0.0875 M anhydrous sodium carbonate, pH 9.6). Wells were washed three times each with 0.05% Tween-20 in PBS (PBST, pH 7.4) and deionized water (DW), then blocked with 3% bovine serum albumin (BSA) in PBS for 1 h at room temperature (RT). After washing, samples and standards were added and incubated for 1 h at RT. Again, after washing, subsequent steps were performed with biotin-conjugated anti-mouse IL-10 followed by avidin-conjugated with horseradish peroxidase (HRP-Avidin; BioLegend) and 3,3′,5,5′-tetramethylbenzidine (TMB) substrate (BioLegend), all with wash steps in between. IL-10 was detected following the addition of 100 μl of 2 N sulfuric acid (H2SO4) to terminate the reaction. Optical density (OD) was measured at 450 nm within 30 min of acid addition. Quantification of IL-10 was performed by generation of a standard curve using recombinant mouse IL-10.
+ Open protocol
+ Expand
2

Blocking Antibodies and Mcl-1 Inhibitor Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following blocking antibodies were used: 10–20 μg/mL anti-mouse GM-CSF blocking antibody (eBioscience, San Diego, CA, USA), 20 μg/mL anti-mouse VEGF, 20 μg/mL anti-mouse IL-10, 10 μg/mL anti-human GM-CSF, 10 μg/mL anti-human VEGF and 20 μg/mL anti-human IL-10 blocking antibodies (R&D systems, Minneapolis, MN, USA). Isotype controls used were 10 μg/mL rat IgG2aK isotype control (eBioscience) and normal goat IgG control (R&D). Mcl-1 inhibitor MIM1 (R&D) was dissolved in DMSO.
+ Open protocol
+ Expand
3

Quantifying Cytokine Levels via ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISA was performed based on the protocol described previously10 (link). Immunol 2HB-microtiter plates were coated with mouse anti IL-10 (R&D Systems) or mouse anti-IL12 (BD Biosciences) followed by blocking with 2% BSA-PBS for 2 hr. Culture supernatants or diluted sera were added after washing and incubated overnight at 4 °C. Secondary Ab labeled with biotin were added to plates, and incubated for 2 hr. Next plates were developed by phosphatase-conjugated streptavidin (AKP) followed by the addition of p-nitrophenyl phosphatase (pNPP) substrate (Southern Biotech). Optical density was measured using a SpectraMax M5 microplate Reader and SoftMax Pro Acquisition and Analysis software (Molecular Devices).
+ Open protocol
+ Expand
4

Quantification of Anti-Cytokine Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunol 2HB-microtiter plates were coated with human anti-TNFα (R&D Systems), mouse anti-IL12 (BD Biosciences), mouse anti-TNFα (R&D Systems) or mouse anti-IL-10 (R&D Systems) and then blocked with 2% BSA-PBS for 2 hr. After washing, culture supernatants or serially diluted sera were added overnight at 4° C. Plates were washed, incubated with biotin-labeled secondary Ab and developed by adding phosphatase-conjugated streptavidin (AKP) followed by p-nitrophenyl phosphatase (pNPP) substrate (Southern Biotech). Optical density was measured using a SpectraMax M5 microplate Reader and SoftMax Pro Acquisition and Analysis software (Molecular Devices).
IgG anti-dsDNA was detected by coating Immunol 2HB-microtiter plates with 4 μg/ml of CT-DNA (Sigma) in DNA binding solution (Abcam) for 4 hr. The plates were blocked with 2% BSA-PBS and incubated with diluted mouse serum as above. Bound Ab was detected with biotin labeled IgG (Invitrogen) followed by phosphate-conjugated streptavidin and pNPP substrate.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!